- Home
- FTEL vs CINGW Comparison
FTEL vs CINGW Comparison
Compare FTEL & CINGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTEL
- CINGW
- Stock Information
- Founded
- FTEL 2007
- CINGW N/A
- Country
- FTEL Australia
- CINGW United States
- Employees
- FTEL N/A
- CINGW 13
- Industry
- FTEL
- CINGW Biotechnology: Pharmaceutical Preparations
- Sector
- FTEL
- CINGW Health Care
- Exchange
- FTEL Nasdaq
- CINGW Nasdaq
- Market Cap
- FTEL 9.6M
- CINGW N/A
- IPO Year
- FTEL 2023
- CINGW 2021
- Fundamental
- Price
- FTEL $0.52
- CINGW $0.03
- Analyst Decision
- FTEL
- CINGW
- Analyst Count
- FTEL 0
- CINGW 0
- Target Price
- FTEL N/A
- CINGW N/A
- AVG Volume (30 Days)
- FTEL 102.7K
- CINGW N/A
- Earning Date
- FTEL 05-20-2025
- CINGW N/A
- Dividend Yield
- FTEL N/A
- CINGW N/A
- EPS Growth
- FTEL N/A
- CINGW N/A
- EPS
- FTEL N/A
- CINGW N/A
- Revenue
- FTEL $4,990,695.00
- CINGW N/A
- Revenue This Year
- FTEL N/A
- CINGW N/A
- Revenue Next Year
- FTEL N/A
- CINGW N/A
- P/E Ratio
- FTEL N/A
- CINGW N/A
- Revenue Growth
- FTEL 29.02
- CINGW N/A
- 52 Week Low
- FTEL $0.43
- CINGW N/A
- 52 Week High
- FTEL $49.50
- CINGW N/A
- Technical
- Relative Strength Index (RSI)
- FTEL 38.58
- CINGW N/A
- Support Level
- FTEL $0.61
- CINGW N/A
- Resistance Level
- FTEL $0.55
- CINGW N/A
- Average True Range (ATR)
- FTEL 0.06
- CINGW 0.00
- MACD
- FTEL 0.04
- CINGW 0.00
- Stochastic Oscillator
- FTEL 53.65
- CINGW 0.00
About FTEL Fitell Corporation
Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains. The company earns maximum of revenue for retail.
About CINGW Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.